SCHEMBL3786271

SCHEMBL3786271

CNC(=O)c1cccc(C(=O)NC)c1Cl

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 2/20 0.57
GAA P10253 1/20 0.55
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
P2RX7 Q99572 1/20 0.46
PDK2 Q15119 1/20 0.45
MTNR1A P48039 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
BRD4 O60885 2/20 0.44
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44
BRDT Q58F21 1/20 0.44
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43
JAK2 O60674 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4143751 0.90 TAS1R3 (0.60) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL31547716 0.88 TAS1R3 (0.54) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL21391472 0.88 PLK1 (0.50) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL7981657 0.88 TAS1R3 (0.54) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL10156678 0.86 P2RX7 (0.50) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL1742047 0.86 GAA (0.67) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL24252064 0.83 CTSS (0.47) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL10156545 0.83 GAA (0.49) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL7984064 0.82 CTSS (0.63) GAAP2RX7PDK2
SCHEMBL13070932 0.80 SLC6A2 (0.58) ALDH1A1POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 PLK1 799/4885GAA 1755/4885TAS1R3 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.